Answers are grounded in this paper and cite their sources.
AIM: A pharmacoeconomic analysis of direct costs on treatment with high dose intravenous immunoglobulins (IVIG) and plasmapheresis (PP) in children. MATERIAL AND METHODS: Literature data on the pathogenesis of Guillain-Barre syndrome (GBS) were analyzed. The results of pharmacoeconomic analysis of direct costs on treatment of GBS using IVIG and PP are presented. Risks for complications during treatment with IVIG and PP are calculated. RESULTS AND CONCLUSION: week of disease showed a marked positive effect.
No takes yet. Share an insight, caveat, or question.
Shakaryan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: